BNGO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bionano Genomics Inc

Watchlist Manager

Watchlist

Price: 1.48 USD 2.07%

Market Cap: $17m

	Bionano Genomics Inc NASDAQ:BNGO	US
S	Scentre Group OTC:STGPF	AU
	Sanmina Corp NASDAQ:SANM	US
M	Master Drilling Group Ltd JSE:MDI	ZA
C	China Construction Bank Corp SWB:C6T	CN

Profitability Summary

Bionano Genomics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Sustainable 3Y Average Gross Margin

25%

Gross Margin is Increasing

27% > 48%

Negative Operating Margin

-107%

Negative 3Y Average Operating Margin

-216%

Operating Margin is Increasing

-442% > -107%

Negative Net Margin

-107%

Negative 3Y Average Net Margin

-326%

Net Margin is Increasing

-676% > -107%

Negative Free Cash Flow Margin

-68%

Negative 3Y Average Free Cash Flow Margin

-180%

Free Cash Flow Margin is Increasing

-391% > -68%

Negative ROE

-84%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-75%

ROIC is Increasing

-127% > -75%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Sustainable 3Y Average Gross Margin

25%

Gross Margin is Increasing

27% > 48%

Negative Operating Margin

-107%

Negative 3Y Average Operating Margin

-216%

Operating Margin is Increasing

-442% > -107%